LEONI, VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 512
EU - Europa 198
AS - Asia 88
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 801
Nazione #
US - Stati Uniti d'America 505
SE - Svezia 44
CN - Cina 39
IT - Italia 36
DE - Germania 27
SG - Singapore 24
IE - Irlanda 22
RU - Federazione Russa 16
VN - Vietnam 13
DK - Danimarca 11
GB - Regno Unito 10
UA - Ucraina 7
CA - Canada 6
FR - Francia 6
BE - Belgio 5
FI - Finlandia 4
TR - Turchia 4
AT - Austria 3
CZ - Repubblica Ceca 2
EU - Europa 2
HK - Hong Kong 2
ID - Indonesia 2
IN - India 2
NL - Olanda 2
PT - Portogallo 2
AU - Australia 1
JP - Giappone 1
KR - Corea 1
MX - Messico 1
PL - Polonia 1
Totale 801
Città #
Ann Arbor 137
Fairfield 53
Wilmington 44
Chandler 37
Woodbridge 29
Cambridge 23
Dublin 22
Singapore 22
Ashburn 21
Dearborn 21
Frankfurt am Main 20
Seattle 16
Houston 14
New York 14
Nanjing 10
Princeton 10
Santa Clara 10
Dong Ket 9
Jacksonville 9
Milan 9
Lawrence 5
Brussels 4
Grafing 4
Guangzhou 4
Rome 4
Shanghai 4
Altamura 3
Hangzhou 3
Helsinki 3
Kunming 3
Vienna 3
Boardman 2
Bonndorf 2
Brno 2
Edmonton 2
Fort Worth 2
Fuzhou 2
Hong Kong 2
Istanbul 2
Jakarta 2
Lissone 2
Merate 2
San Diego 2
Shenyang 2
Stockholm 2
Toronto 2
Ancona 1
Andover 1
Auma 1
Bloomingdale 1
Bloomsbury 1
Brendola 1
Brussel 1
Changsha 1
Chicago 1
Cuajimalpa 1
Desio 1
Edinburgh 1
Hefei 1
Jinan 1
Kraków 1
Kwangju 1
Lachine 1
Lisbon 1
Loreto 1
Melzo 1
Mountain View 1
Nanchang 1
Ottawa 1
Paris 1
Sassari 1
Stony Brook 1
Sulmona 1
Taizhou 1
Turin 1
Valdagno 1
Wuhan 1
Totale 631
Nome #
Predictive value of minimal residual disease in philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies 288
Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: High white blood cell count at diagnosis is the strongest prognostic factor 187
Tyrosine kinase inhibitors in BCR-ABL positive acute lymphoblastic leukemia 130
Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial 129
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols 124
Totale 858
Categoria #
all - tutte 2.892
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.892


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020137 0 0 0 0 16 22 21 19 19 22 13 5
2020/2021193 7 11 18 15 9 20 23 29 14 13 10 24
2021/202273 5 8 11 3 4 9 6 4 5 1 7 10
2022/2023132 15 49 6 13 6 19 1 12 6 0 4 1
2023/202466 1 3 2 6 8 18 15 4 2 0 0 7
2024/202573 11 15 19 13 15 0 0 0 0 0 0 0
Totale 858